To determine whether the benefits of antihypertensive treatment vary according to dipper status, 811 asymptomatic elderly Japanese hypertensives underwent 24-h ambulatory blood pressure monitoring. During a mean follow-up period of 41 months, 32 stroke events were observed in patients who remained nonmedicated (n ϭ 385), and in 27 patients in the medicated group (n ϭ 426), indicating a 24% lower rate of stroke as a result of antihypertensive therapy. Patients were divided into a whitecoat hypertensive (WCHT) group (ambulatory blood pressure Ͻ130/80 mm Hg; n ϭ 236) and a sustained hypertensive (SHT) group (n ϭ 575). Sixty-one percent of SHT and 32% of WCHT patients were being medicated. In the SHT group, the stroke rates were 12.4% in nonmedicated and 7.4% in medicated group (P ϭ .04), whereas in the WCHT group the stroke rates were 2.5% in nonmedicated and 1.3% in medicated group (P ϭ not significant). The SHT were further classified according to their nocturnal systolic blood pressure (BP) decrease, as follows: 97 extreme-dippers with Ͼ20% nocturnal systolic BP decrease; 230 dippers with Ͼ10% but Ͻ20% decrease; 185 nondippers with Ͼ0% but Ͻ10% decrease; 63 reversedippers with Ͻ0% decrease. In the dipping groups of SHT, the stroke rates were similar according to medication versus no-medication in extreme-dippers (12% v 13%), and reverse-dippers (23% v 22%), but in nondippers there was a significantly lower rate (by 65%, P ϭ .038) in the medicated (4.4%) than the nonmedicated (13%) groups. In dippers, the stroke rate was also lower in the medicated than the nonmedicated patients (4.7% v 8.8%), a decrease of 47% (P ϭ .217), although the difference was not significant. In conclusion, in older SHT subjects, antihypertensive therapy using clinic BP may be less effective for the groups with extremely abnormal diurnal BP patterns (extreme-dippers and reverse-dippers) than those with relatively normal patterns (dippers and nondippers). Patients with WCHT also showed no benefit. Am J Hypertens 2002;15:844 -850
A
majority of previous reports have demonstrated that the risk of cardiovascular events increases linearly with blood pressure (BP) in adult samples of the general population. 1 However, some articles have reported a J-curve relationship between BP and cardiovascular events, particularly between diastolic BP (DBP) and coronary heart disease. 2, 3 Recently, a few prospective studies in older hypertensive subjects have shown a Jcurve relationship between BP and stroke events in medicated patients. 4, 5 The first, a subanalysis of the Systolic Hypertension in the Elderly Program (SHEP) showed that a decrease in DBP increased the risk of stroke, coronary heart disease, and cardiovascular disease in the active treatment group. 4 The second, a prospective cohort study in an elderly Dutch population demonstrated a J-curve relationship between BP, particularly significant in DBP and stroke risk. 5 A meta-analysis of clinical trials of antihypertensive drug therapy concluded that antihypertensive therapy might increase the total mortality of people more than 80 years old. 6 These results suggested that there may be groups of patients in whom the relationship is nonlinear or J-shaped, and we speculate that there may be some in whom aggressive antihypertensive treatment might not have any benefit.
Previous articles have shown that a smaller than normal nocturnal BP decrease is associated with cardiovascular disease. [7] [8] [9] [10] [11] We have recently found that elderly hypertensive extreme-dippers with marked nocturnal BP decrease showed more advanced silent cerebrovascular disease (silent infarction and advanced ischemic deep white matter lesion) detected by brain magnetic resonance imaging (MRI) than hypertensive dippers with an appropriate decrease. 12 In these hypertensive patients, antihypertensive treatment might increase the stroke risk due to reduction of nocturnal cerebral perfusion. In one study using ambulatory blood pressure monitoring (ABPM) in postischemic stroke patients, dippers developed recurrent stroke more frequently during antihypertensive treatment than nondippers. 13 We have also encountered extreme-dippers who developed clinical stroke while on antihypertensive therapy. 14, 15 These findings suggest that some patients with low nighttime BP are at increased risk of stroke during antihypertensive therapy.
On the other hand, reverse dippers with higher nocturnal BP than daytime BP also have adverse cardiovascular outcomes. 16 In this group, the control of daytime clinical BP may be inadequate to suppress the hypertension-related worse outcomes.
To determine whether the benefits of antihypertensive treatment vary according to dipping status, stroke prognosis was investigated in 811 asymptomatic elderly Japanese hypertensives who underwent 24-h ABPM and were subsequently followed for an average of 41 months.
Methods

Subjects
This study is based on 811 elderly Japanese subjects diagnosed with essential hypertension. This represents 99% of the 823 subjects who were initially enrolled into the study from six participating institutions (three clinics, two hospitals, and one outpatient clinic of the university hospital) between January 1, 1992, and January 1, 1998. 17 Hypertensive patients were selected by the following criteria: 1) essential hypertension with average clinic systolic BP (SBP) Ͼ140 mm Hg or average clinic DBP of Ͼ90 mm Hg (average for each patient on two or more occasions); and 2) age Ͼ50 years. Clinic BP was measured after resting for at least 5 min in the sitting position. No patient had taken any antihypertensive medication for at least 14 days before the ABPM study. All of the subjects studied were ambulatory, and all gave informed consent for the study. We excluded from this study patients with renal failure (serum creatinine level, Ͼ176 mmol/L) or hepatic damage or with obvious present illness or past history of coronary artery disease, stroke (including transient ischemic attacks [TIA]), congestive heart failure, or arrhythmia. Results of the ABPM were given to the treating physicians. This study was approved by the Institutional Review Board at the Department of Cardiology, Jichi Medical School.
Diabetes mellitus was defined by a fasting glucose level Ͼ7.8 mmol/L, a random nonfasting glucose level Ͼ11.1 mmol/L, hemoglobin A1c Ͼ6.2%, or the use of an oral hypoglycemic agent or insulin. Hyperlipidemia was defined by a total cholesterol level Ͼ6.2 mmol/L or the use of an oral lipid-lowering agent. Smokers were defined as current smokers. Body mass index (BMI) was calculated as weight (kilograms)/height (meters 2 ). Electrocardiographically verified left ventricular hypertrophy (ECG-LVH) was defined as abnormally high voltages of QRS complexes (R in V 5 plus S in V 1 Ͼ3.5 mV) associated either with flat T-waves (Ͻ10% of R) or with ST-segment depression and biphasic T-waves.
24-Hour ABPM
Noninvasive ABPM was carried out on a weekday with one of three automatic ABPM devices (ABPM-630, Nippon Colin Co.; TM-2421/2425, A&D Co., Japan), which recorded BP and heart rate every 30 min for 24 h. The accuracy of these devices was previously validated. The ambulatory data used in the present study were those obtained by the oscillometric method. We excluded those who obtained valid BP readings Ͻ80% of either awake attempts or asleep attempts (n ϭ 51). Those who reported that their sleep was severely disturbed due to the ABPM (compared with their normal sleep pattern) were also excluded from this study (n ϭ 39). Sleep BP was defined as the average of BP from the time when the patients went to bed to the time they got out of bed, and awake BP as the average of BP recorded during the rest of the day. The nocturnal SBP decrease (percentage was calculated as 100 (1 Ϫ sleep SBP/awake SBP).
Follow-Up and Events
The patients' medical records have been intermittently reviewed since entering the study for drug therapy and the occurrence of stroke events. The dipping results were not specifically communicated to the patients' treating physicians, but the mean awake and sleep BP and pulse rates were. The follow-up evaluation was performed during a 20-month period from 1996 to 1998, and the mean follow-up period was 41 months, with a range from 1 to 68 months. When subjects stopped coming to the clinic, we conducted telephone interviews with them. The stroke events were accepted if documented in the medical records, or if confirmed by the general practitioner. We excluded 12 "possible TIA episodes" from the stroke events. Of the total 823 eligible subjects at baseline, follow-up was obtained in 811 (99%) subjects, and the data analysis was restricted to these subjects.
Statistical Analysis
Data are expressed as the mean (SD). One-way analysis of variance was performed to detect differences among groups in mean values, and the 2 test was used to detect differences among groups in prevalence rates. Adjusted relative risks (RR) and 95% confidence intervals were calculated using Cox regression analysis. These statistics were performed using SPSS version 8.0J (SPSS Inc., Chicago, IL). Differences with P Ͻ .05 were considered statistically significant.
Results
During the mean follow-up period of 41 months, 32 stroke events (8.3%) were observed in patients who remained untreated (n ϭ 385), and 27 events (6.3%) in treated patients (n ϭ 426), indicating a 24% lower rate of stroke as a result of antihypertensive therapy (P ϭ .280).
Study patients were divided into a white-coat hypertensive (WCHT) group (n ϭ 236) and a sustained hypertensive (SHT) group (n ϭ 575), according to the recommendation of American Society of Hypertension 18 as follows: 24-h ABPM Ͻ130/80 mm Hg (both) for WCHT; 24-h ABPM Ͼ130/80mm Hg (either) for SHT. Sixty-one percent of SHT patients were being medicated, and 32% of WCHT. In the SHT patients, the medicated group had higher ABPM levels than the nonmedicated group (Table  1) . In the SHT, the stroke rate were 12.4% in nonmedicated and 7.4% in medicated patients (P ϭ .04), whereas in the WCHT the stroke rates were 2.5% in nonmedicated and 1.3% (P ϭ not significant) in medicated patients.
The SHT group was further classified according to nocturnal SBP decrease, 12 as follows: 97 extreme-dippers with Ͼ20% nocturnal SBP decrease; 230 dippers with Ͼ10% but Ͻ20% decrease; 185 nondippers with Ͼ0% but Ͻ10% decrease; 63 reverse-dippers with Ͻ0% decrease. In the dippers and nondippers, the medicated group had higher ABPM levels than the nonmedicated group, whereas there were no significant differences in ABPM levels between the two groups in the extreme-dippers and reverse-dippers (Table 2 ). In the dipping groups of SHT, the stroke rates were similar according to medication versus nonmedication in extreme-dippers (12% v 13%), and reverse-dippers (23% v 22%), but in nondippers there was a significantly lower rate (by 65%, P ϭ .038) in the medicated (4.4%) than the nonmedicated (13%) patients (Fig. 1) . In dippers, the stroke rate was also lower in the medicated than the nonmedicated patients (4.7% v 8.8%), a decrease of 47%, although the difference was not significant (P ϭ .217).
In this hypertensive elderly population, the mean Ϯ SD nocturnal SBP dipping was 12% Ϯ 9%, and 72% of all subjects were classified as dippers or nondippers. In addition, the stroke incidence rates of the dippers and nondippers were comparable (6.1% for dippers and 7.6% for Abbreviations as in Table 1 . * P Ͻ .05 v nonmedicated within the same groups. † P Ͻ .01 v nonmedicated within the same groups. ‡ P Ͻ .001 v nonmedicated within the same groups.
nondippers; P ϭ .550). Thus, we considered dippers and nondippers as the relative normal dipping group (n ϭ 415) in this elderly hypertensive population, and extreme-dippers and reverse-dippers as the extremely abnormal dipping group (n ϭ 160). In the relatively normal dipping group, the stroke rate was significantly lower (by 57%, P ϭ .018) in the medicated (4.5%) than the nonmedicated (10.6%) groups. Adjusted for age, gender, BMI, 24-h SBPM, smoking, diabetes, hyperlipidemia, and ECG-LVH, a 36% reduction (P ϭ .135) of stroke incidence by antihypertensive medication was found in the total group (Fig. 2) . The benefit of antihypertensive medication was only found in the relatively normal dipping group (P Ͻ .049), but it was absent in the extremely abnormal dipping group.
When we classified the SHT patients into quintiles (Q) of sleep SBP, stroke risk was only higher in the highest group (stroke incidence, 7.0% for Q1; 7.9% for Q2; 7.8% for Q3; 6.1% for Q4; 18.1% for Q5).
Discussion
This study first indicates that the benefit of antihypertensive treatment varies according to dipping status in older Japanese subjects with sustained hypertension. In this group, antihypertensive therapy, based primarily on clinic BP, may be less effective for those with the most abnormal diurnal BP patterns (extreme-dippers and reverse-dippers) than for those with relatively normal patterns (dippers and nondippers). Patients with WCHT also showed no benefit.
Overall Benefit
The reduction of stroke by antihypertensive medication was 36% in the entire sample of elderly hypertensive persons after controlling for demographic data and target organ damage (ECG-LVH). This reduction rate was similar to those of previous clinical trials in elderly hypertensive patients ( 19 Thus, when we consider the elderly hypertensive population as a whole, antihypertensive mediation is clearly beneficial for the prevention of stroke events.
White-Coat Hypertension
When we divided the study subjects into WCHT and SHT groups, 61% of SHT patients were being treated, as were 32% of WCHT. In the SHT, the stroke rates were significantly higher in the nonmedicated than in the medicated groups (12.4% v 7.4%, P ϭ .04). The stroke incidences in the WCHT group were less than SHT, and we could not detect a significant difference between the medicated and nonmedicated groups of the WCHT group. A recent analysis of the double-blind placebo-controlled Syst-Eur trial of elderly persons with isolated systolic hypertension showed that WCHT subjects showed lower cardiovascular complications than the SHT subjects, and a significant benefit of antihypertensive medication was demonstrated only in the SHT group. 20 Considering these results, the utility of antihypertensive medication for preventing cardiovascular disease in elderly hypertensive patients is more limited in WCHT patients than in SHT patients.
Differences Among Dipping Groups
In the SHT, the reduction of stroke events by antihypertensive medication was limited in the two most extreme 
FIG. 2.
Adjusted stroke reduction rates by antihypertensive medication in sustained hypertensive patients with extremely abnormal (extreme-dippers and reverse-dippers) and relatively normal (dippers and nondippers) dipping status. Adjusted for age, gender, body mass index, 24-h systolic blood pressure, smoking, diabetes, hyperlipidemia, and electrocardiographically verified left ventricular hypertrophy.
abnormal nocturnal BP dipping groups (extreme-dippers and reverse-dippers), compared to the two intermediate dipping groups (dippers and nondippers). The stroke reduction rates were 5% lower for those on medication (versus those not on medication) for the former two groups, and 57% for the latter groups after controlling for demographic data and ECG-LVH. This indicates that the benefit of antihypertensive treatment, predominantly prescribed on the basis of clinic BP by each physician is limited in elderly hypertensives with extremely abnormal dipping status. Our previous study using brain MRI showed that both extreme abnormal dipping groups (extreme-dippers and reverse-dippers) have higher rates of advanced silent cerebral infarcts, 12 which is the most powerful predictor of clinically overt stroke, 21 than dippers. In extreme dippers, we hypothesize that as the threshold of BP needed to maintain blood flow shifts to a higher level in elderly subjects with hypertension and silent cerebral infarcts, antihypertensive therapy triggers ischemic stroke events through additional reduction of nocturnal cerebral perfusion in extreme-dippers. Similar antihypertensive medication-related adverse outcomes have been reported in extreme-dippers with coronary artery disease. 22 In hypertensive patients with coronary artery stenosis who exhibited extreme-dipping patterns of nocturnal BP, silent myocardial ischemia detected by ambulatory Holter-ECG monitoring was increased during the night period after antihypertensive medication was started, whereas the nocturnal ischemia was decreased in the nondippers. Another article showed that hypertensives with LVH experience nocturnal ischemia in association with medication-induced decrease in DBP. 23 On the other hand, the explanation for the poor stroke reduction benefit of antihypertensive therapy in reversedippers may be that BP control maintained by clinic BP is insufficient, particularly during the night. This incomplete BP reduction might advance hypertensive target organ damage and promote subsequent stroke events in reversedippers. Another possibility is that this abnormal diurnal BP variation pattern is associated with autonomic nervous system dysfunction, and increased BP variability. 24 -26 In addition to ordinal antihypertensive therapy, some additional attempts to reduce nocturnal BP, and BP variability, might be necessary for these high-risk hypertensives.
Study Limitation
The number of the events is relatively small, and the design of the present study is not placebo controlled. As elderly hypertensive patients with extreme abnormal dipping patterns (extreme-dippers and reverse-dippers) are at the highest risk for cardiovascular events, more effective antihypertensive medication or other prevention strategies may be necessary. As this is an observational prospective study, we could not control the decision of each physician or patient on the antihypertensive medication during the follow-up period. A double-blind placebo-controlled study is necessary to confirm the limited benefit for antihypertensive therapy in elderly hypertensives with unusual dipping patterns and, especially, the beneficial effects on stroke reduction of normalizing someone's abnormal extreme dipping pattern.
Although we have data on medication status at the time of follow-up, we inadvertently failed to obtain medication data for the time period between the ABPM assessment and the final follow-up evaluation. Therefore, we are unable to adjust completely for the possibilities that some persons may only have been on medication for a short time at the follow-up examination whereas others could have been taking medication for much of the follow-up period but been off medication at the time of the follow-up.
Relative Hypotension in Elderly Hypertensives
In addition to the extreme-dipping pattern, other relative hypotensive conditions found in elderly hypertensives are orthostatic hypotension and postprandial hypotension. 27 Reverse-dippers might alternatively be consider as experiencing a relative daytime hypotensive condition. Recent precise assessment for hypertensive cerebrovascular disease using brain MRI disclosed that all of these relative hypotensive conditions are associated with advanced silent cerebral infarcts in elderly subjects. 12, 28, 29 In addition, these hypotensive conditions also predict clinical stroke in the elderly hypertensive population. 17, 30 We propose that all these relative hypotensive episodes may be detected by ABPM. More precise individualized BP control for these older hypertensive patients with relative hypotensive episodes could more effectively prevent hypotension-related events such as ischemic stroke, vascular dementia, and falls.
